Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 31-40 of 90 (Search time: 0.005 seconds).
previous
1
2
3
4
5
6
7
...
9
next
Item hits:
Preview
Issue Date
Title
Author(s)
2006
Autologous stem cell collection and autograft for patients with chronic myeloid leukemia in the era of ABL kinase inhibitors: Back to the bench
Hui, C.
;
Hughes, T.
2013
Proton pump inhibitors significantly increase the intracellular concentration of nilotinib, but not imatinib in target CML cells
White, D.
;
Eadie, L.
;
Saunders, V.
;
Hiwase, D.
;
Hughes, T.
2010
Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: implications for combination TKI therapy
Hiwase, D.
;
White, D.
;
Zrim, S.
;
Saunders, V.
;
Vaz de Melo, J.
;
Hughes, T.
2005
Dynamics of chronic myeloid leukaemia
Michor, F.
;
Hughes, T.
;
Iwasa, Y.
;
Branford, S.
;
Shah, N.
;
Sawyers, C.
;
Nowak, M.
2013
NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisis
Watkins, D.
;
Hughes, T.
;
White, D.
;
D'Andrea, R.
2011
OCT-1 as a determinant of response to antileukemic treatment
Engler, J.
;
Hughes, T.
;
White, D.
2013
Low GFI1 expression in white blood cells of CP-CML patients at diagnosis is strongly associated with subsequent blastic transformation
Kok, C.
;
Watkins, D.
;
Leclercq, T.
;
D'Andrea, R.
;
Hughes, T.
;
White, D.
2011
Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial
Kantarjian, H.
;
Hochhaus, A.
;
Saglio, G.
;
de Souza, C.
;
Flinn, I.
;
Stenke, L.
;
Goh, Y.
;
Rosti, G.
;
Nakamae, H.
;
Gallagher, N.
;
Hoenekopp, A.
;
Blakesley, R.
;
Larson, R.
;
Hughes, T.
2004
Monitoring of minimal residual disease in chronic myeloid leukemia
Faderl, S.
;
Hochhaus, A.
;
Hughes, T.
2008
International standardisation of quantitative real-time RT-PCR for BCR-ABL
Cross, N.
;
Hughes, T.
;
Hochhaus, A.
;
Goldman, J.
Discover
Author
32
White, D.
24
Branford, S.
23
Hochhaus, A.
13
Radich, J.
12
Kantarjian, H.
12
Saglio, G.
11
Cortes, J.
11
Larson, R.
11
Saunders, V.
10
Kim, D.
.
next >
Subject
60
Leukemia, Myelogenous, Chronic, B...
59
Pyrimidines
52
Imatinib Mesylate
51
Piperazines
50
Benzamides
39
Antineoplastic Agents
36
Fusion Proteins, bcr-abl
34
Protein Kinase Inhibitors
31
Male
29
Female
.
next >
Date issued
1
2020 - 2022
45
2010 - 2019
40
2000 - 2009
4
1995 - 1999